Velaglucerase alfa is indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease. Gaucher…
Vimzim is mainly composed of the most important substance known as Elosulfase Alfa. It is used to treat…
Strensiq or asfotase alfa is indicated for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP). HPP…
Elosulfase alfa, marketed under the brand name Vimizim™, is a recombinant form of the enzyme N-acetylgalactosamine-6-sulfatase, manufactured by…